- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Dr Gurpreet Sandhu (Managing Director) REVA PHARMA - Delegation Visit | 18 September, 2015
Dr Gurpreet Sandhu (Managing Director) REVA PHARMA was member of the India Delegation which visited HQ of Meiji Seika Pharmaceutical Co (Japan) on 18th September 2015. The objective of the joint meet was to impress upon Meiji Seika for investment in India (Make in India) programme.​